ABS has developed a proprietary stenting technology designed to treat bifurcation lesions

Founded with a mission to improve patient outcomes and simplify complex cardiovascular procedures, ABS has developed a proprietary stenting technology designed to treat bifurcation lesions more effectively. These lesions occur when plaque builds up at the junction of two arteries, creating significant challenges for conventional stenting techniques. The cornerstone of ABS’s innovation is its bifurcation stent, which is engineered to provide better coverage and support at the artery junctions. This stent system simplifies the procedure, reduces the risk of complications, and improves long−term outcomes for patients. The design allows for a single stent deployment, eliminating the need for multiple stents and reducing the complexity of the procedure.